Cytarabine 61703-0319-22

Package NDC

61703-0319-22

Manufacturer: Hospira, Inc.
Dosage Form: Injection, Solution
Route: Intrathecal, Intravenous, And Subcutaneous
Product Type: Human Prescription Drug
Marketing Start: November 22, 1999
Listing Expires: December 31, 2026
Application: ANDA075383

Need to source Cytarabine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Cytarabine	100 mg/mL

Drug Class

Nucleoside Metabolic Inhibitor [EPC]Nucleic Acid Synthesis Inhibitors [MoA]Nucleoside Metabolic Inhibitor [EPC]

Selected Package

61703-0319-22Selected

1 VIAL, SINGLE-DOSE in 1 CARTON (61703-319-22) / 20 mL in 1 VIAL, SINGLE-DOSE